National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting, 53148-53149 [2013-20976]

Download as PDF wreier-aviles on DSK5TPTVN1PROD with NOTICES 53148 Federal Register / Vol. 78, No. 167 / Wednesday, August 28, 2013 / Notices Control and Prevention (CDC), announces the following meeting for the aforementioned subcommittee: Time and Date: 10:00 a.m.–5:00 p.m., September 30, 2013. Place: Audio Conference Call via FTS Conferencing. The USA toll-free, dial-in number is 1–866–659–0537 and the pass code is 9933701. Status: Open to the public, but without a public comment period. To access by conference call dial the following information 1(866) 659–0537, Participant Pass Code 9933701. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2015. Purpose: The Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee for Dose Reconstruction Reviews was established to aid the Advisory Board in carrying out its duty to advise the Secretary, HHS, on dose reconstruction. VerDate Mar<15>2010 15:21 Aug 27, 2013 Jkt 229001 Matters to Be Discussed: The agenda for the Subcommittee meeting includes: dose reconstruction program quality management and assurance activities, including: current findings from NIOSH internal dose reconstruction blind reviews; and discussion of dose reconstruction cases under review (set 9, and Rocky Flats Plant, Los Alamos National Laboratory, and Paducah and Portsmouth Gaseous Diffusion Plants cases from sets 10–13). The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below well in advance of the meeting. Contact Person for More Information: Theodore Katz, Designated Federal Official, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30333, Telephone (513) 533–6800, Toll Free 1(800) CDC–INFO, Email ocas@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–20973 Filed 8–27–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting Name: ICD–9–CM Coordination and Maintenance (C&M) Committee meeting. Time and Date: 9:00 a.m.–5:00 p.m., September 18–19, 2013. Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. We will be broadcasting the PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 meeting live via Webcast at hhtp:// www.cms.gov/live/. Security Considerations: Due to increased security requirements CMS has instituted stringent procedures for entrance into the building by nongovernment employees. Attendees will need to present valid government-issued picture identification, and sign-in at the security desk upon entering the building. Attendees who wish to attend the September 18–19, 2013, ICD–9–CM C&M meeting must submit their name and organization by September 6, 2013, for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Participants who attended previous ICD–9–CM C&M meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you wish attend. Please register to attend the meeting on-line at: https://www.cms.hhs.gov/ apps/events/. Please contact Mady Hue (410–786– 4510 or Marilu.hue@cms.hhs.gov), for questions about the registration process. Purpose: The ICD–9–CM Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Ninth Revision, Clinical Modification, the International Classification of Diseases, Tenth Revision, Clinical Modification and ICD–10-Procedure Coding System. Matters To Be Discussed: Agenda items include: September 18–19, 2013. ICD–10 Topics: Insertion of bone graft Implantation of neurostimulation device ICD–10 Updates ICD–10–CM Diagnosis Topics: Gastrointestinal Stromal Tumors Hearing Loss Low lying placenta Mental and Behavioral disorders Neurology topics Observation and evaluation for newborns Oromaxillofacial Disorders Pediatric topics Periorbital and Preseptal Cellulitis Periprosthetic Fractures Traumatic Brain Injury Unintended awareness under general anesthesia Vaccine and prophylactic immunotherapy administration ICD– 10–CM Addendum Agenda items are subject to change as priorities dictate. Note: CMS and NCHS will no longer provide paper copies of handouts for the E:\FR\FM\28AUN1.SGM 28AUN1 Federal Register / Vol. 78, No. 167 / Wednesday, August 28, 2013 / Notices meeting. Electronic copies of all meeting materials will be posted on the CMS and NCHS Web sites prior to the meeting at https://www.cms.hhs.gov/ ICD9ProviderDiagnosticCodes/03_ meetings.asp#TopOfPage and https:// www.cdc.gov/nchs/icd/icd9cm_ maintenance.htm Cindy Melanson, (410) 786–0310. Patricia Chmielewski, (410) 786–6899. SUPPLEMENTARY INFORMATION: Contact Persons for Additional Information: Donna Pickett, Medical Systems Administrator, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road, Room 2337, Hyattsville, Maryland 20782, email dfp4@cdc.gov, telephone 301–458–4434 (diagnosis); Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Boulevard, Baltimore, Maryland, 21244, email marilu.hue@cms.hhs.gov, telephone 410–786–4510 (procedures). The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–20976 Filed 8–27–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3281–FN] Medicare and Medicaid Programs: Continued Approval of American Osteopathic Association/Healthcare Facilities Accreditation Program (AOA/ HFAP’s) Hospital Accreditation Program Centers for Medicare & Medicaid Services, HHS. ACTION: Final notice. AGENCY: This final notice announces our decision to approve American Osteopathic Association/Healthcare Facilities Accreditation Program (AOA/ HFAP) for continued recognition as a national accrediting organization for hospitals that wish to participate in the Medicare or Medicaid programs. DATES: This final notice is effective September 25, 2013 through September 25, 2019. FOR FURTHER INFORMATION CONTACT: Valarie Lazerowich, (410) 786–4750. wreier-aviles on DSK5TPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 15:21 Aug 27, 2013 Jkt 229001 I. Background Under the Medicare program, eligible beneficiaries may receive covered services in a hospital provided certain requirements are met. Section 1861(e) of the Social Security Act (the Act) establishes distinct criteria for facilities seeking designation as a hospital. Regulations concerning provider agreements are at 42 CFR part 489 and those pertaining to activities relating to the survey and certification of facilities are at 42 CFR part 488. The regulations at 42 CFR part 482 specify the conditions that a hospital must meet to participate in the Medicare program, the scope of covered services, and the conditions for Medicare payment for hospitals. Generally, to enter into an agreement, a hospital must first be certified by a State survey agency as complying with the conditions or requirements set forth in part 482. Thereafter, the hospital is subject to regular surveys by a State survey agency to determine whether it continues to meet these requirements. However, there is an alternative to surveys by state agencies. Certification by a nationally recognized accreditation program can substitute for ongoing state review. Section 1865(a)(1) of the Act provides that, if a provider entity demonstrates through accreditation by an approved national accrediting organization that all applicable Medicare conditions are met or exceeded, CMS will deem those provider entities as having met the requirements. Accreditation by an accrediting organization is voluntary and is not required for Medicare participation. If an accrediting organization is recognized by the Secretary of the Department of Health and Human Services as having standards for accreditation that meet or exceed Medicare requirements, any provider entity accredited by the national accrediting body’s approved program would be deemed to have met the Medicare conditions. A national accrediting organization applying for approval of its accreditation program under part 488, subpart A, must provide CMS with reasonable assurance that the accrediting organization requires the accredited provider entities to meet requirements that are at least as stringent as the Medicare conditions. Our regulations concerning the approval of accrediting organizations are set forth at § 488.4 and § 488.8(d)(3). The regulations at § 488.8(d)(3) require PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 53149 accrediting organizations to reapply for continued approval of its accreditation program every 6 years or sooner as determined by CMS. The American Osteopathic Association/Healthcare Facilities Accreditation Program’s (AOA/HFAP) current term of approval for their hospital accreditation program expires September 25, 2013. II. Application Approval Process Section 1865(a)(3)(A) of the Act provides a statutory timetable to ensure that our review of applications for CMSapproval of an accreditation program is conducted in a timely manner. The Act provides us 210 days after the date of receipt of a complete application, with any documentation necessary to make the determination, to complete our survey activities and application process. Within 60 days after receiving a complete application, we must publish a notice in the Federal Register that identifies the national accrediting body making the request, describes the request, and provides no less than a 30day public comment period. At the end of the 210-day period, we must publish a notice in the Federal Register approving or denying the application. III. Provisions of the Proposed Notice On March 22, 2013, we published a proposed notice in the Federal Register (78 FR 17677) announcing AOA/HFAP’s request for approval of its hospital accreditation program. In the proposed notice, we detailed our evaluation criteria. Under section 1865(a)(2) of the Act and in our regulations at § 488.4 and § 488.8, we conducted a review of AOA/ HFAP’s application in accordance with the criteria specified by our regulations, which include, but are not limited to the following: • An onsite administrative review of AOA/HFAP’s: (1) Corporate policies; (2) financial and human resources available to accomplish the proposed surveys; (3) procedures for training, monitoring, and evaluation of its surveyors; (4) ability to investigate and respond appropriately to complaints against accredited facilities; and (5) survey review and decisionmaking process for accreditation. • The comparison of AOA/HFAP’s accreditation to our current Medicare hospital conditions of participation. • A documentation review of AOA/ HFAP’s survey process to: ++ Determine the composition of the survey team, surveyor qualifications, and AOA/HFAP’s ability to provide continuing surveyor training. ++ Compare AOA/HFAP’s processes to those of state survey agencies, including survey frequency, and the E:\FR\FM\28AUN1.SGM 28AUN1

Agencies

[Federal Register Volume 78, Number 167 (Wednesday, August 28, 2013)]
[Notices]
[Pages 53148-53149]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-20976]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Health Statistics (NCHS), Classifications and 
Public Health Data Standards Staff, Announces the Following Meeting

    Name: ICD-9-CM Coordination and Maintenance (C&M) Committee 
meeting.
    Time and Date: 9:00 a.m.-5:00 p.m., September 18-19, 2013.
    Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 
7500 Security Boulevard, Baltimore, Maryland 21244.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 240 people. We will be 
broadcasting the meeting live via Webcast at hhtp://www.cms.gov/live/.
    Security Considerations: Due to increased security requirements CMS 
has instituted stringent procedures for entrance into the building by 
non-government employees. Attendees will need to present valid 
government-issued picture identification, and sign-in at the security 
desk upon entering the building. Attendees who wish to attend the 
September 18-19, 2013, ICD-9-CM C&M meeting must submit their name and 
organization by September 6, 2013, for inclusion on the visitor list. 
This visitor list will be maintained at the front desk of the CMS 
building and used by the guards to admit visitors to the meeting.
    Participants who attended previous ICD-9-CM C&M meetings will no 
longer be automatically added to the visitor list. You must request 
inclusion of your name prior to each meeting you wish attend.
    Please register to attend the meeting on-line at: https://www.cms.hhs.gov/apps/events/.
    Please contact Mady Hue (410-786-4510 or Marilu.hue@cms.hhs.gov), 
for questions about the registration process.
    Purpose: The ICD-9-CM Coordination and Maintenance (C&M) Committee 
is a public forum for the presentation of proposed modifications to the 
International Classification of Diseases, Ninth Revision, Clinical 
Modification, the International Classification of Diseases, Tenth 
Revision, Clinical Modification and ICD-10-Procedure Coding System.
    Matters To Be Discussed: Agenda items include: September 18-19, 
2013.
    ICD-10 Topics:

Insertion of bone graft
Implantation of neurostimulation device
ICD-10 Updates
    ICD-10-CM Diagnosis Topics:

Gastrointestinal Stromal Tumors
Hearing Loss
Low lying placenta
Mental and Behavioral disorders
Neurology topics
Observation and evaluation for newborns
Oromaxillofacial Disorders
Pediatric topics
Periorbital and Preseptal Cellulitis
Periprosthetic Fractures
Traumatic Brain Injury
Unintended awareness under general anesthesia
Vaccine and prophylactic immunotherapy administration ICD-10-CM 
Addendum
    Agenda items are subject to change as priorities dictate.

    Note:  CMS and NCHS will no longer provide paper copies of 
handouts for the

[[Page 53149]]

meeting. Electronic copies of all meeting materials will be posted 
on the CMS and NCHS Web sites prior to the meeting at https://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage and https://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm

    Contact Persons for Additional Information: Donna Pickett, Medical 
Systems Administrator, Classifications and Public Health Data Standards 
Staff, NCHS, 3311 Toledo Road, Room 2337, Hyattsville, Maryland 20782, 
email dfp4@cdc.gov, telephone 301-458-4434 (diagnosis); Mady Hue, 
Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security 
Boulevard, Baltimore, Maryland, 21244, email marilu.hue@cms.hhs.gov, 
telephone 410-786-4510 (procedures).
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-20976 Filed 8-27-13; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.